AU2002351240A8 - Gold nanoparticles used for x-rays imaging - Google Patents

Gold nanoparticles used for x-rays imaging

Info

Publication number
AU2002351240A8
AU2002351240A8 AU2002351240A AU2002351240A AU2002351240A8 AU 2002351240 A8 AU2002351240 A8 AU 2002351240A8 AU 2002351240 A AU2002351240 A AU 2002351240A AU 2002351240 A AU2002351240 A AU 2002351240A AU 2002351240 A8 AU2002351240 A8 AU 2002351240A8
Authority
AU
Australia
Prior art keywords
gold nanoparticles
nanoparticles used
rays imaging
rays
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351240A
Other versions
AU2002351240A1 (en
Inventor
Daniel Slatkin
James Hainfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002351240A8 publication Critical patent/AU2002351240A8/en
Publication of AU2002351240A1 publication Critical patent/AU2002351240A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414Particles, beads, capsules or spheres
    • A61K49/0423Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414Particles, beads, capsules or spheres
    • A61K49/0423Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A61K49/0428Surface-modified nanoparticles, e.g. immuno-nanoparticles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002351240A 2002-03-08 2002-12-04 Gold nanoparticles used for x-rays imaging Abandoned AU2002351240A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9404102A 2002-03-08 2002-03-08
US10/094,041 2002-03-08
PCT/US2002/038850 WO2003075961A2 (en) 2002-03-08 2002-12-04 Gold nanoparticles used for x-rays imaging

Publications (2)

Publication Number Publication Date
AU2002351240A8 true AU2002351240A8 (en) 2003-09-22
AU2002351240A1 AU2002351240A1 (en) 2003-09-22

Family

ID=27804244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351240A Abandoned AU2002351240A1 (en) 2002-03-08 2002-12-04 Gold nanoparticles used for x-rays imaging

Country Status (2)

Country Link
AU (1) AU2002351240A1 (en)
WO (1) WO2003075961A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004098649A2 (en) * 2003-05-06 2004-11-18 Philips Intellectual Property & Standards Gmbh Apparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent
US20070031339A1 (en) * 2003-11-28 2007-02-08 Oskar Axelsson Contrast agents
WO2005070473A1 (en) * 2004-01-15 2005-08-04 Koninklijke Philips Electronics N.V. Ultrasound contrast agents for molecular imaging
NO20052429D0 (en) * 2005-05-20 2005-05-20 Amersham Health As The contrast agents
NO20052428D0 (en) * 2005-05-20 2005-05-20 Amersham Health As contrast agents
US9149545B2 (en) 2005-11-02 2015-10-06 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same
US20070122620A1 (en) * 2005-11-02 2007-05-31 General Electric Company Nanoparticle-based imaging agents for x-ray / computed tomography and methods for making same
US7977568B2 (en) 2007-01-11 2011-07-12 General Electric Company Multilayered film-nanowire composite, bifacial, and tandem solar cells
US8003883B2 (en) 2007-01-11 2011-08-23 General Electric Company Nanowall solar cells and optoelectronic devices
US20100166664A1 (en) * 2008-12-29 2010-07-01 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US8574549B2 (en) * 2008-12-29 2013-11-05 General Electric Company Nanoparticle contrast agents for diagnostic imaging
WO2011097824A1 (en) * 2010-02-12 2011-08-18 大连科林爱纳米科技有限公司 Preparation method of nano-gold particles used as contrast agent for x-ray or computerized tomography (ct)
ES2636908T3 (en) 2010-04-27 2017-10-10 Ventana Medical Systems, Inc. Nanoparticle-antibody conjugates and procedures for producing and using said conjugates
EP2593186A1 (en) * 2010-07-16 2013-05-22 Technical University of Denmark Nanoparticle-guided radiotherapy
WO2012170569A1 (en) * 2011-06-06 2012-12-13 State Of Oregon By And Through The State Board Of Higher Education On Behalf Of Portland State University Bismuth particle x-ray contrast agents
JP6042450B2 (en) * 2011-12-16 2016-12-14 ナノビオティックスNanobiotix Nanoparticles comprising metal materials and hafnium oxide materials, their manufacture and use
WO2016054079A1 (en) 2014-09-29 2016-04-07 Zyomed Corp. Systems and methods for blood glucose and other analyte detection and measurement using collision computing
CN107708668A (en) 2015-05-28 2018-02-16 纳米生物技术公司 Nano-particle as therapeutic vaccine
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
US20190001001A1 (en) * 2017-07-03 2019-01-03 General Electric Company Drug design for application-dependent payload, controlled pharmacokinetic distribution, and renal clearance
WO2023101745A2 (en) * 2021-09-09 2023-06-08 NU Planet Holding Co. Radioisotope generator, apparatus, system and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10330288A (en) * 1997-06-03 1998-12-15 Mitsubishi Chem Corp Metal fine particle complex and contrast media by using the same
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization

Also Published As

Publication number Publication date
WO2003075961A3 (en) 2003-12-18
WO2003075961A2 (en) 2003-09-18
AU2002351240A1 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
AU2002351240A8 (en) Gold nanoparticles used for x-rays imaging
EP1593091A4 (en) High contrast optoacoustical imaging using nanoparticles
AU2002348320A8 (en) X-ray fluoroscopic imaging
GB2427073B (en) Imaging device
AU2003264858A8 (en) Reduced size imaging device
EP1593999A4 (en) Imaging device
GB2393347B (en) Imaging device
GB0212001D0 (en) X-ray image detector
EP1778089A4 (en) Arrangement for intra-oral x-ray imaging
AU2002357361A1 (en) X-ray imaging device
GB2406380B (en) Imaging device
EP1691394A4 (en) X-ray apparatus
HK1075126A1 (en) X-ray microscope
EP1701375A4 (en) X-ray apparatus
AU2003213186A8 (en) Independent component imaging
EP1686608A4 (en) X-ray apparatus
AU2003222014A8 (en) Miniaturized imaging device
GB0404223D0 (en) X-ray inspection system
GB0215248D0 (en) Imaging apparatus
EP1533847A4 (en) Solid imaging device
GB2398449B (en) Imaging apparatus
HK1077964A1 (en) X-ray device
AU2003224917A8 (en) Diabetes imaging probes
GB0224770D0 (en) Imaging device
EP1675151A4 (en) X-ray apparatus

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase